BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25771001)

  • 1. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a.
    Bhattacharya S; Ahir M; Patra P; Mukherjee S; Ghosh S; Mazumdar M; Chattopadhyay S; Das T; Chattopadhyay D; Adhikary A
    Biomaterials; 2015 May; 51():91-107. PubMed ID: 25771001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
    Upadhyay P; Sarker S; Ghosh A; Gupta P; Das S; Ahir M; Bhattacharya S; Chattopadhyay S; Ghosh S; Adhikary A
    Biomater Sci; 2019 Oct; 7(10):4325-4344. PubMed ID: 31411213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
    Ahmad R; Kaus NHM; Hamid S
    Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells.
    Ibrahim WN; Muizzuddin Bin Mohd Rosli L; Doolaanea AA
    Int J Nanomedicine; 2020; 15():8059-8074. PubMed ID: 33116518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
    Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
    Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone-Loaded Soluplus
    Bergonzi MC; Vasarri M; Marroncini G; Barletta E; Degl'Innocenti D
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
    Shaarani S; Hamid SS; Mohd Kaus NH
    Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.
    Shabani H; Karami MH; Kolour J; Sayyahi Z; Parvin MA; Soghala S; Baghini SS; Mardasi M; Chopani A; Moulavi P; Farkhondeh T; Darroudi M; Kabiri M; Samarghandian S
    Biomed Pharmacother; 2023 Sep; 165():114972. PubMed ID: 37481931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer.
    Bhattacharya S; Ghosh A; Maiti S; Ahir M; Debnath GH; Gupta P; Bhattacharjee M; Ghosh S; Chattopadhyay S; Mukherjee P; Adhikary A
    J Control Release; 2020 Jun; 322():357-374. PubMed ID: 32243981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis.
    Prajapati C; Agrawal YO; Agnihotri VV; Mahajan UB; Patil KR; Patil DD; Patil CR
    Int J Biol Macromol; 2022 Aug; 214():391-401. PubMed ID: 35714868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
    Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone inhibits the migration of mouse neuroblastoma (Neuro-2a) cells by down-regulating MMP-2 and MMP-9.
    Arumugam P; Subramanian R; Priyadharsini JV; Gopalswamy J
    Chin J Nat Med; 2016 Dec; 14(12):904-912. PubMed ID: 28262117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
    Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
    Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M
    Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterisation of PEG modified chitosan nanocapsules loaded with thymoquinone.
    Vignesh Kumar SK; Renuka Devi P; Harish S; Hemananthan E
    IET Nanobiotechnol; 2017 Feb; 11(1):104-112. PubMed ID: 28476970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway.
    Woo CC; Loo SY; Gee V; Yap CW; Sethi G; Kumar AP; Tan KH
    Biochem Pharmacol; 2011 Sep; 82(5):464-75. PubMed ID: 21679698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.